FDA Orange Book
Is there a generic for Eysuvis?
Eysuvis contains loteprednol etabonate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Eysuvis (loteprednol etabonate). The Orange Book shows its last listed patent expires May 3, 2033.
Run it in Rivvi
Map Eysuvis and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Eysuvis products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| suspension/drops, ophthalmic | 0.25% | Marketed (Rx) | None | 0 | None |
NDA 210933, held by ALCON LABORATORIES INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Eysuvis patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 11219596 | May 3, 2033 | Method of use | U-2985 | 210933 |
| 11596599 | May 3, 2033 | Method of use | U-2985 | 210933 |
| 10857096 | May 3, 2033 | Method of use | U-2985 | 210933 |
| 10945948 | May 3, 2033 | Method of use | U-2985 | 210933 |
| 10940108 | May 3, 2033 | Method of use | U-2985 | 210933 |
| 9532955 | May 3, 2033 | Method of use | U-2491 | 210933 |
| 9737491 | May 3, 2033 | Method of use | U-2492 | 210933 |
| 9056057 | May 3, 2033 | Drug product | U-2491 | 210933 |
| 9827191 | May 3, 2033 | Drug product | U-2985 | 210933 |
| 10058511 | May 3, 2033 | Drug product | U-2492 | 210933 |
| 10993908 | May 3, 2033 | Method of use | U-3117 | 210933 |
| 12115246 | May 3, 2033 | Drug product | U-2985 | 210933 |
| 11642317 | May 3, 2033 | Drug product | None | 210933 |
| 10688045 | May 3, 2033 | Drug product | None | 210933 |
| 10646436 | May 3, 2033 | Drug product | None | 210933 |
| 9393213 | May 3, 2033 | Drug product | None | 210933 |
| 11872318 | May 3, 2033 | Drug product | None | 210933 |
Eysuvis NDC codes
Questions
Is there a generic for Eysuvis?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Eysuvis (loteprednol etabonate). The Orange Book shows its last listed patent expires May 3, 2033.
What is the generic name for Eysuvis?
The active ingredient in Eysuvis is loteprednol etabonate, per the FDA Orange Book.
When does the Eysuvis patent expire?
The last patent listed for Eysuvis in the Orange Book expires May 3, 2033. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Eysuvis and Loteprednol Etabonate
- What is Eysuvis used for?FDA label uses
- Is Eysuvis a controlled substance?Federal schedule
- What is Loteprednol Etabonate used for?FDA label uses
- Is Loteprednol Etabonate a controlled substance?Federal schedule
- Generic for LotemaxFDA Orange Book
- Generic for Lotemax SMFDA Orange Book
- Generic for AlrexFDA Orange Book
- Generic for InveltysFDA Orange Book
- Corticosteroids listFDA drug class
- NDC 71571-333Eysuvis NDC record